Buisson Rémi, Niraj Joshi, Rodrigue Amélie, Ho Chu Kwen, Kreuzer Johannes, Foo Tzeh Keong, Hardy Emilie J-L, Dellaire Graham, Haas Wilhelm, Xia Bing, Masson Jean-Yves, Zou Lee
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.
CHU de Québec Research Center, Oncology Axis, Department of Molecular Biology, Medical Biochemistry, and Pathology, Laval University Cancer Research Center, Laval University, Québec City, QC G1V 0A6, Canada.
Mol Cell. 2017 Jan 19;65(2):336-346. doi: 10.1016/j.molcel.2016.12.007. Epub 2017 Jan 12.
ATR is a key regulator of cell-cycle checkpoints and homologous recombination (HR). Paradoxically, ATR inhibits CDKs during checkpoint responses, but CDK activity is required for efficient HR. Here, we show that ATR promotes HR after CDK-driven DNA end resection. ATR stimulates the BRCA1-PALB2 interaction after DNA damage and promotes PALB2 localization to DNA damage sites. ATR enhances BRCA1-PALB2 binding at least in part by inhibiting CDKs. The optimal interaction of BRCA1 and PALB2 requires phosphorylation of PALB2 at S59, an ATR site, and hypo-phosphorylation of S64, a CDK site. The PALB2-S59A/S64E mutant is defective for localization to DNA damage sites and HR, whereas the PALB2-S59E/S64A mutant partially bypasses ATR for its localization. Thus, HR is a biphasic process requiring both high-CDK and low-CDK periods. As exemplified by the regulation of PALB2 by ATR, ATR promotes HR by orchestrating a "CDK-to-ATR switch" post-resection, directly coupling the checkpoint to HR.
ATR是细胞周期检查点和同源重组(HR)的关键调节因子。矛盾的是,ATR在检查点反应期间抑制CDK,但高效的HR需要CDK活性。在此,我们表明ATR在CDK驱动的DNA末端切除后促进HR。DNA损伤后,ATR刺激BRCA1与PALB2的相互作用,并促进PALB2定位于DNA损伤位点。ATR至少部分通过抑制CDK来增强BRCA1与PALB2的结合。BRCA1与PALB2的最佳相互作用需要PALB2在S59(一个ATR作用位点)处磷酸化,以及在S64(一个CDK作用位点)处低磷酸化。PALB2-S59A/S64E突变体在定位于DNA损伤位点和HR方面存在缺陷,而PALB2-S59E/S64A突变体在定位于DNA损伤位点时部分绕过了ATR的作用。因此,HR是一个双相过程,需要高CDK期和低CDK期。以ATR对PALB2的调节为例,ATR通过在切除后协调一个“CDK到ATR的转换”来促进HR,直接将检查点与HR联系起来。